Chai Discovery Series C Valuation Hits $3.8B in 2026
A 2026 analyst report on Chai Discovery's $400M Series C at a $3.8B valuation, covering Chai-3 benchmarks, Lilly, Pfizer, Novartis, and argenx deals, and AI drug discovery megaround trends.
Back to Articles
Articles tagged with “venture-funding-2026”